Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model

European Journal of Immunology

Volumn 35, Issue 11, 2005, Pages 3277-3286

  Kootiratrakarn, Tanawatt ^a   Fujimura, Taku ^a   Sano, Kunio ^a   Okuyama, Ryuhei ^a   Aiba, Setsuya ^a   Tagami, Hachiro ^a   Terui, Tadashi ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergy; Eosinophils; Skin; Th1 Th2 cells

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; SKIN INFLAMMATION; SKIN SENSITIZATION; TH2 CELL;

ANIMALS; CELL MOVEMENT; CPG ISLANDS; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; RNA, MESSENGER; SKIN; TH2 CELLS;

EID: 27944503308     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526274     Document Type: Article

References (38)

1. Leung, D. Y., Atopic dermatitis: New insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 2000. 105: 860-876.
2. Verboom, P., Hakkaart-Van, L., Sturkenboom, M., De Zeeuw, R., Menke, H. and Rutten, F., The cost of atopic dermatitis in the Netherlands: an international comparison. Br. J. Dermatol 2002. 147: 716-724.
3. Okada, M., Terui, T., Honda, M., Tanaka, M., Chikama, R., Tabata, N., Takahashi, K. et al., Cutaneous late phase reaction in adult atopic dermatitis patients with high serum IgE antibody to Dermatophagoides farinae: correlation with IL-5 production by allergen-stimulated peripheral blood mononuclear cells. J. Dermatol. Sci. 2002. 29: 73-84.
4. Ying, S., Kikuchi, Y., Meng, Q., Kay, A. B. and Kaplan, A. P., TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J. Allergy Clin. Immunol. 2002. 109: 694-700.
5. Terui, T., Sano, K., Okada, M., Shirota, H., Honda, M., Ozawa, M., Hirasawa, N. et al., Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells. J. Invest. Dermatol. 2001. 117: 236-243.
6. Terui, T., Sano, K., Shirota, H., Kunikata, N., Ozawa, M., Okada, M., Honda, M. et al., TGF-β-producing CD4 mediastinal lymph node cells obtained from mice tracheally tolerized to ovalbumin (OVA) suppress both Th1- and Th2-induced cutaneous inflammatory responses to OVA by different mechanisms. J. Immunol. 2001. 167: 3661-3667.
7. Kitagaki, H., Ono, N., Hayakawa, K., Kitazawa, T., Watanabe, K. and Shiohara, T., Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 1997. 159: 2484-2491.
8. Spergel, J. M., Mizoguchi, E., Brewer, J. P., Martin, T. R., Bhan, A. K. and Geha, R. S., Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 1998. 101: 1614-1622.
9. von Hertzen, L. C., Puzzling associations between childhood infections and the later occurrence of asthma and atopy. Ann. Med. 2000. 32: 397-400.
10. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709-760.
11. Raz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J. A., Roman, M., Swain, S. L. et al., Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 1996. 93: 5141-5145.
12. Kunikata, N., Sano, K., Honda, M., Ishii, K., Matsunaga, J., Okuyama, R., Takahashi, K., Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells. J. Invest. Dermatol. 2004. 123: 395-402.
13. Shirota, H., Sano, K., Kikuchi, T., Tamura, G. and Shirato, K., Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J. Immunol. 2000. 164: 5575-5582.
14. Schneider, L. C., New treatment for atopic dermatitis. Immunol. Allergy Clin. North Am. 2002. 22: 141-152.
15. Leung, D. Y., Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 1999. 104: S99-S108.
16. Clark, R. A. and Adinoff, A. D., Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool. J. Am. Acad. Dermatol. 1989. 21: 863-869.
17. Tupker, P. A., De Monchy, J. G., Coenraads, P. J., Homan, A. and van der Meer, J. B., Induction of atopic dermatitis by inhalation of housedust mite. J. Allergy Clin. Immunol. 1996. 97: 1064-1070.
18. Sidbury, R. and Hanifin, J. M., Systemic therapy of atopic dermatitis. Clin. Exp. Dermatol. 2000. 25: 559-566.
19. Marrack, P. and Kappler, J. W., The staphylococcal enterotoxins and their relatives. Science 1990. 248: 705-711.
20. Jung, T., Lack, G., Schauer, U., Uberuck, W., Renz, H., Gelfand, E. W. and Rieger, C. H., Decreased frequency of interferon-gamma- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. J. Allergy Clin. Immunol. 1995. 96: 515-527.
21. Lonati, A., Licenziati, S., Canaris, A. D., Fiorentini, S., Pasolini, G., Marcelli, M., Seidenari, S., Reduced production of both Th1 and Tc1 lymphocyte subsets in atopic dermatitis (AD). Clin. Exp. Immunol. 1999. 115: 1-5.
22. Campbell, D. E., Fryga, A. S., Bol, S. and Kemp, A. S., Intracellular interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis. Clin. Exp. Immunol. 1999. 115: 377-382.
23. Tang, M. and Kemp, A., Production and secretion of interferon-gamma (IFN-gamma) in children with atopic dermatitis. Clin. Exp. Immunol. 1994. 95: 66-72.
24. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
25. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 1997. 3: 849-854.
26. Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F. and Klinman, D. M., Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 2001. 166: 2372-2377.
27. Klinman, D. M., CpG DNA as a vaccine adjuvant. Expert Rev. Vaccines 2003. 2: 305-315.
28. Gangloff, S. C. and Guenounou, M., Toll-like receptors and immune response in allergic disease. Clin. Rev. Allergy Immunol. 2004. 26: 115-125.
29. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. and Harding, C. V., CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 1997. 186: 1623-1631.
30. Chiaramonte, M. G., Hesse, M., Cheever, A. W. and Wynn, T. A., CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 2000. 164: 973-985.
31. Broide, D. H., Stachnick, G., Castaneda, D., Nayar, J., Miller, M., Cho, J. Y., Roman, M. et al., Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J. Clin. Immunol. 2001. 21: 175-182.
32. Hansen, G., Berry, G., DeKruyff, R. H. and Umetsu, D. T., Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 1999. 103: 175-183.
33. Kline, J. N., Krieg, A. M., Waldschmidt, T. J., Ballas, Z. K., Jain, V. and Businga, T. R., CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J. Allergy Clin. Immunol. 1999. 104: 1258-1264.
34. Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M. D., Malek, S., Van Uden, J. et al., Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 1998. 161: 7054-7062.
35. Serebrisky, D., Teper, A. A., Huang, C. K., Lee, S. Y., Zhang, T. F., Schofield, B. H., Kattan, M., CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J. Immunol. 2000. 165: 5906-5912.
36. Lee, J. J., McGarry, M. P., Farmer, S. C., Denzler, K. L., Larson, K. A., Carrigan, P. E., Brenneise, I. E. et al., Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 1997. 185: 2143-2156.
37. Higuchi, R., Fockler, C., Dollinger, G. and Watson, R., Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993. 11: 1026-1030.
38. Holland, P. M., Abramson, R. D., Watson, R. and Gelfand, D. H., Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 1991. 88: 7276-7280.